ibuprofen /ml

PreclinicalSmall molecule

OOctober University for Modern Sciences and Arts

ibuprofen /ml is one of 25 small molecule programs targeting Anxiety. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnxietyActive, not recruiting

AnxietyPreclinical

Active, not recruiting

Competition

Competitive Landscape

165 competitors in Anxiety

#DrugCompanyPhaseTrials

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 3

4 2

Duragesic

CCephalon

Phase 3

1 3

Celexa

AbbVie

Preclinical

1 4

Spravato

WWim Janssens

Preclinical

4 5

Campral

FForest Laboratories

Preclinical

2 6

Luvox

SSolvay Pharmaceuticals

Preclinical

2 7

Anerem

AAcacia Pharma Ltd

Preclinical

2 8

Catapres

Boehringer Ingelheim

Preclinical

1 9

Andriol

AAuxilium

Preclinical

1 10

Intelence

WWim Janssens

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anxiety1 trial

Preemptive Analgesia for Pain and Anxiety Control in Children With MIH

Recruiting·OOctober University for Modern Sciences and Arts·N/A·NCT07374354·46 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for ibuprofen /ml. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ibuprofen /ml compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ibuprofen /ml. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — October University for Modern Sciences and Arts company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: OOctober University for Modern Sciences and Arts

ibuprofen /ml

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anxiety1 trial

References

Drug Info

Quick Facts

Related News